Back to Journals » Neuropsychiatric Disease and Treatment » Volume 13

Neuropsychiatric Disease and Treatment


Archive: Volume 13, 2017

Abnormal regional spontaneous neural activity in visual pathway in retinal detachment patients: a resting-state functional MRI study

Huang X, Li D, Li H, Zhong Y, Freeberg S, Bao J, Zeng X, Shao Y

Neuropsychiatric Disease and Treatment 2017, 13:2849-2854

Published Date: 22 November 2017

Group cognitive–behavioral therapy in insomnia: a cross-sectional case-controlled study

Mao H, Ji Y, Xu Y, Tang G, Yu Z, Xu L, Shen C, Wang W

Neuropsychiatric Disease and Treatment 2017, 13:2841-2848

Published Date: 21 November 2017

Altered microstructure of brain white matter in females with anorexia nervosa: a diffusion tensor imaging study

Hu SH, Feng H, Xu TT, Zhang HR, Zhao ZY, Lai JB, Xu DR, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:2829-2836

Published Date: 21 November 2017

The efficacy of antipsychotics for prolonged delirium with renal dysfunction

Asano S, Kunii Y, Hoshino H, Osakabe Y, Shiga T, Itagaki S, Miura I, Yabe H

Neuropsychiatric Disease and Treatment 2017, 13:2823-2828

Published Date: 16 November 2017

Immigration-related mental health disorders in refugees 5–18 years old living in Turkey

Yalın Sapmaz Ş, Uzel Tanrıverdi B, Öztürk M, Gözaçanlar Ö, Yörük Ülker G, Özkan Y

Neuropsychiatric Disease and Treatment 2017, 13:2813-2821

Published Date: 10 November 2017

Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia

Brasso C, Bellino S, Bozzatello P, Montemagni C, Rocca P

Neuropsychiatric Disease and Treatment 2017, 13:2767-2779

Published Date: 7 November 2017

Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011–2015

Blozik E, Rapold R, Eichler K, Reich O

Neuropsychiatric Disease and Treatment 2017, 13:2737-2745

Published Date: 1 November 2017

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease

Murakami H, Nohara T, Shozawa H, Owan Y, Kuroda T, Yano S, Kezuka M, Kawamura M, Ono K

Neuropsychiatric Disease and Treatment 2017, 13:2719-2726

Published Date: 25 October 2017

Effects of short-term piano training on measures of finger tapping, somatosensory perception and motor-related brain activity in patients with cerebral palsy

Alves-Pinto A, Ehrlich S, Cheng G, Turova V, Blumenstein T, Lampe R

Neuropsychiatric Disease and Treatment 2017, 13:2705-2718

Published Date: 25 October 2017

Transient global amnesia: current perspectives

Spiegel DR, Smith J, Wade RR, Cherukuru N, Ursani A, Dobruskina Y, Crist T, Busch RF, Dhanani RM, Dreyer N

Neuropsychiatric Disease and Treatment 2017, 13:2691-2703

Published Date: 24 October 2017

Association of TNF-alpha G-308A gene polymorphism with depression: a meta-analysis

Shin KH, Jeong HC, Choi DH, Kim SN, Kim TE

Neuropsychiatric Disease and Treatment 2017, 13:2661-2668

Published Date: 20 October 2017

Bupropion interferes with the image diagnosis of Parkinson's disease

Lin CH, Lane HY

Neuropsychiatric Disease and Treatment 2017, 13:2637-2639

Published Date: 19 October 2017

Differences in serum zinc levels in acutely ill and remitted adolescents and young adults with bulimia nervosa in comparison with healthy controls – a cross-sectional pilot study

Zepf FD, Rao P, Runions K, Stewart RM, Moore JK, Wong JWY, Linden M, Sungurtekin I, Glass F, Gut L, Peetz D, Hintereder G, Schaab M, Poustka F, Wöckel L

Neuropsychiatric Disease and Treatment 2017, 13:2621-2630

Published Date: 17 October 2017

Thalamo–cortical network underlying deep brain stimulation of centromedian thalamic nuclei in intractable epilepsy: a multimodal imaging analysis

Kim SH, Lim SC, Yang DW, Cho JH, Son BC, Kim J, Hong SB, Shon YM

Neuropsychiatric Disease and Treatment 2017, 13:2607-2619

Published Date: 17 October 2017

Coping, schemas, and cardiovascular risks – study protocol

Slepecky M, Kotianova A, Prasko J, Majercak I, Gyorgyova E, Kotian M, Zatkova M, Tonhajzerova I, Chupacova M, Popelkova M

Neuropsychiatric Disease and Treatment 2017, 13:2599-2605

Published Date: 13 October 2017

Relationship of negative and positive core beliefs about the self with dysfunctional attitudes in three aspects of life

Otani K, Suzuki A, Matsumoto Y, Shirata T

Neuropsychiatric Disease and Treatment 2017, 13:2585-2588

Published Date: 12 October 2017

Sporadic hyperekplexia due to self-limiting brainstem encephalopathy

Yilmaz D, Cengiz B

Neuropsychiatric Disease and Treatment 2017, 13:2581-2584

Published Date: 9 October 2017

Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders

Finsterer J, Zarrouk-Mahjoub S

Neuropsychiatric Disease and Treatment 2017, 13:2569-2579

Published Date: 6 October 2017

Interpersonal sensitivity mediates the effects of child abuse and affective temperaments on depressive symptoms in the general adult population

Otsuka A, Takaesu Y, Sato M, Masuya J, Ichiki M, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2017, 13:2559-2568

Published Date: 5 October 2017

MLC601 in vascular dementia: an efficacy and safety pilot study

Pakdaman H, Amini Harandi A, Gharagozli K, Abbasi M, Ghaffarpour M, Ashrafi F, Delavar Kasmaei H, Amini Harandi A

Neuropsychiatric Disease and Treatment 2017, 13:2551-2557

Published Date: 5 October 2017

19q12q13.2 duplication syndrome: neuropsychiatric long-term follow-up of a new case and literature update

Nacinovich R, Villa N, Broggi F, Tavaniello C, Bomba M, Conconi D, Redaelli S, Sala E, Lavitrano M, Neri F

Neuropsychiatric Disease and Treatment 2017, 13:2545-2550

Published Date: 4 October 2017

Children with borderline intellectual functioning and autism spectrum disorder: developmental trajectories from 4 to 11 years of age

Barnevik Olsson M, Holm A, Westerlund J, Lundholm Hedvall Å, Gillberg C, Fernell E

Neuropsychiatric Disease and Treatment 2017, 13:2519-2526

Published Date: 4 October 2017

Frequencies of circulating B- and T-lymphocytes as indicators for stroke outcomes

Wang Y, Liu J, Wang X, Liu Z, Li F, Chen F, Geng X, Ji Z, Du H, Hu X

Neuropsychiatric Disease and Treatment 2017, 13:2509-2518

Published Date: 3 October 2017

Motivation to change and posttreatment temptation to drink: a multicenter study among alcohol-dependent patients

Fiabane E, Ottonello M, Zavan V, Pistarini C, Giorgi I

Neuropsychiatric Disease and Treatment 2017, 13:2497-2504

Published Date: 3 October 2017

Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study

Kitahata R, Nakajima S, Uchida H, Hayashida T, Takahashi M, Nio S, Hirano J, Nagaoka M, Suzuki T, Jinno H, Kitagawa Y, Mimura M

Neuropsychiatric Disease and Treatment 2017, 13:2489-2496

Published Date: 3 October 2017

Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides

Li Y, Su R, Xu S, Huang Q, Xu H

Neuropsychiatric Disease and Treatment 2017, 13:2477-2487

Published Date: 27 September 2017

Laser interstitial thermal therapy for the treatment of epilepsy: evidence to date

Shukla ND, Ho AL, Pendharkar AV, Sussman ES, Halpern CH

Neuropsychiatric Disease and Treatment 2017, 13:2469-2475

Published Date: 26 September 2017

Atypical depression: current perspectives

Łojko D, Rybakowski JK

Neuropsychiatric Disease and Treatment 2017, 13:2447-2456

Published Date: 20 September 2017

Factors associated with bullying victimization among Korean adolescents

Seo HJ, Jung YE, Kim MD, Bahk WM

Neuropsychiatric Disease and Treatment 2017, 13:2429-2435

Published Date: 18 September 2017

Need for medication to complement catecholamines in smoking cessation of hardcore smokers

Kawai A, Kurita M, Nishino S, Hirata E, Sato T, Okubo Y

Neuropsychiatric Disease and Treatment 2017, 13:2419-2424

Published Date: 18 September 2017

Sex differences in obesity and cognitive function in a cognitively normal aging Chinese Han population

Li W, Qiu Q, Sun L, Yue L, Wang T, Li X, Xiao S

Neuropsychiatric Disease and Treatment 2017, 13:2405-2410

Published Date: 14 September 2017

Depression and family support in breast cancer patients

Su JA, Yeh DC, Chang CC, Lin TC, Lai CH, Hu PY, Ho YF, Chen VC, Wang TN, Gossop M

Neuropsychiatric Disease and Treatment 2017, 13:2389-2396

Published Date: 13 September 2017

Triadic interactions in families with preterm children: a comparative study with children born at term

Gatta M, Miscioscia M, Svanellini L, Brianda ME, Guerra G, Battistella PA, Simonelli A

Neuropsychiatric Disease and Treatment 2017, 13:2375-2388

Published Date: 13 September 2017

Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan

Sugawara N, Kaneda A, Takahashi I, Nakaji S, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2017, 13:2369-2374

Published Date: 12 September 2017

Low uric acid is a risk factor in mild cognitive impairment

Xue L, Liu Y, Xue H, Xue J, Sun K, Wu L, Hou P

Neuropsychiatric Disease and Treatment 2017, 13:2363-2367

Published Date: 11 September 2017

Natural reduced water suppressed anxiety and protected the heightened oxidative stress in rats

Masuda K, Tanaka Y, Kanehisa M, Ninomiya T, Inoue A, Higuma H, Kawashima C, Nakanishi M, Okamoto K, Akiyoshi J

Neuropsychiatric Disease and Treatment 2017, 13:2357-2362

Published Date: 8 September 2017

Cognitive behavioral therapy for somatic symptom disorders in later life: a prospective comparative explorative pilot study in two clinical populations

Verdurmen MJH, Videler AC, Kamperman AM, Khasho D, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2017, 13:2331-2339

Published Date: 1 September 2017

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?

Hu JB, Lai JB, Hu SH, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:2327-2330

Published Date: 31 August 2017

Sociodemographic variables and social values: relationship with work-attendance problems in Brunei public- and private-sector employees

Mundia L, Mahalle S, Matzin R, Zakaria GAN, Abdullah NZM

Neuropsychiatric Disease and Treatment 2017, 13:2307-2319

Published Date: 31 August 2017

Risk of post-traumatic epilepsy after severe head injury in patients with at least one seizure

Chen W, Li MD, Wang GF, Yang XF, Liu L, Meng FG

Neuropsychiatric Disease and Treatment 2017, 13:2301-2306

Published Date: 30 August 2017

Effects of bromadiolone poisoning on the central nervous system

Wang M, Yang Y, Hou Y, Ma W, Jia R, Chen J

Neuropsychiatric Disease and Treatment 2017, 13:2297-2300

Published Date: 30 August 2017

A case of schizophrenia comorbid for tetralogy of Fallot treated with clozapine: further considerations on a role for 22q.11.2 in the proneness for seizures

Kashiwagi H, Ikezawa S, Sumiyoshi T, Kadono A, Segawa K, Takeda K, Omori M, Taguchi H, Hirabayashi N

Neuropsychiatric Disease and Treatment 2017, 13:2271-2273

Published Date: 29 August 2017

Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia

Emsley R, Hargarter L, Bergmans P, Uglešić B, Sengül AC, Petralia A, Khannanova A, Cherubin P, Schreiner A

Neuropsychiatric Disease and Treatment 2017, 13:2261-2269

Published Date: 29 August 2017

Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy [Corrigendum]

Alkholy UM, Abdalmonem N, Zaki A, Ali YF, Mohamed SA, Abdelsalam NI, Abu Hashim MI, Abou Sekkien M, Elsherbiny YM

Neuropsychiatric Disease and Treatment 2017, 13:2255-2256

Published Date: 26 August 2017

Fan the flame: trazodone-induced mania in a unipolar depressed patient with stable sertraline treatment

Hu JB, Lai JB, Zheng HZ, Hu SH, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:2251-2254

Published Date: 24 August 2017

Analyzing a single nucleotide polymorphism in schizophrenia: a meta-analysis approach

Falola O, Osamor VC, Adebiyi M, Adebiyi E

Neuropsychiatric Disease and Treatment 2017, 13:2243-2250

Published Date: 23 August 2017

Antipsychotic-associated weight gain: management strategies and impact on treatment adherence

Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA

Neuropsychiatric Disease and Treatment 2017, 13:2231-2241

Published Date: 22 August 2017

Association between COMT Val158Met and DAT1 polymorphisms and depressive symptoms in the obese population

Bieliński M, Jaracz M, Lesiewska N, Tomaszewska M, Sikora M, Junik R, Kamińska A, Tretyn A, Borkowska A

Neuropsychiatric Disease and Treatment 2017, 13:2221-2229

Published Date: 18 August 2017

Improvements in motor tasks through the use of smartphone technology for individuals with Duchenne muscular dystrophy

Capelini CM, Silva TD, Tonks J, Watson S, Alvarez MPB, Menezes LDC, Favero FM, Caromano FA, Massetti T, de Mello Monteiro CB

Neuropsychiatric Disease and Treatment 2017, 13:2209-2217

Published Date: 18 August 2017

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Mathews M, Feng Y, Yu L, Takahashi M, Liu D, Wang G, Yoon J, Chen JJ

Neuropsychiatric Disease and Treatment 2017, 13:2193-2207

Published Date: 17 August 2017

Feasibility of cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study

Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M

Neuropsychiatric Disease and Treatment 2017, 13:2185-2191

Published Date: 16 August 2017

Bipolar II disorder as the initial presentation of CADASIL: an underdiagnosed manifestation

Wang J, Li J, Kong F, Lv H, Guo Z

Neuropsychiatric Disease and Treatment 2017, 13:2175-2179

Published Date: 14 August 2017

Can melatonin prevent or improve metabolic side effects during antipsychotic treatments?

Porfirio MC, Gomes de Almeida JP, Stornelli M, Giovinazzo S, Purper-Ouakil D, Masi G

Neuropsychiatric Disease and Treatment 2017, 13:2167-2174

Published Date: 10 August 2017

Factors associated with failure to achieve remission and with relapse after remission in patients with major depressive disorder in the PERFORM study

Saragoussi D, Touya M, Haro JM, Jönsson B, Knapp M, Botrel B, Florea I, Loft H, Rive B

Neuropsychiatric Disease and Treatment 2017, 13:2151-2165

Published Date: 9 August 2017

Early predictors of brain damage in full-term newborns with hypoxic ischemic encephalopathy

Alkholy UM, Abdalmonem N, Zaki A, Ali YF, Mohamed SA, Abdelsalam NI, Abu Hashim MI, Abou Sekkien M, Elsherbiny YM

Neuropsychiatric Disease and Treatment 2017, 13:2133-2139

Published Date: 8 August 2017

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis

Kuga A, Tsuji T, Hayashi S, Matsubara M, Fujikoshi S, Tokuoka H, Yoshikawa A, Escobar R, Tanaka K, Azekawa T

Neuropsychiatric Disease and Treatment 2017, 13:2105-2114

Published Date: 4 August 2017

Which psychological, psychophysiological, and anthropometric factors are connected with life events, depression, and quality of life in patients with cardiovascular disease

Slepecky M, Kotianova A, Prasko J, Majercak I, Gyorgyova E, Kotian M, Zatkova M, Popelkova M, Ociskova M, Tonhajzerova I

Neuropsychiatric Disease and Treatment 2017, 13:2093-2104

Published Date: 4 August 2017

Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein–Barr virus infection in adults

Guo YJ, Wang SH, Jiang B, Li JL, Liu L, Wang J, Zhao WQ, Jia J

Neuropsychiatric Disease and Treatment 2017, 13:2085-2092

Published Date: 3 August 2017

Suicidal and homicidal tendencies after Lyme disease: an ignored problem

Munir A, Aadil M, Rehan Khan A

Neuropsychiatric Disease and Treatment 2017, 13:2069-2071

Published Date: 2 August 2017

La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder

van Meerkerk-Aanen PJ, de Vroege L, Khasho D, Foruz A, van Asseldonk JT, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2017, 13:2057-2067

Published Date: 2 August 2017

Safety and efficacy of paliperidone palmitate 1-month formulation in Chinese patients with schizophrenia: a 25-week, open-label, multicenter, Phase IV study

Zhao JP, Li LH, Shi JG, Li Y, Xu XF, Li KQ, Zhang LL, Cai SL, Feng Y, Zhuo JM, Liu WH, Lu HF

Neuropsychiatric Disease and Treatment 2017, 13:2045-2056

Published Date: 2 August 2017

MicroRNA expression profiles in chronic epilepsy rats and neuroprotection from seizures by targeting miR-344a

Liu XX, Liao YH, Wang XX, Zou DH, Luo C, Jian CD, Wu Y

Neuropsychiatric Disease and Treatment 2017, 13:2037-2044

Published Date: 31 July 2017

Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study

Durgam S, Landbloom RP, Mackle M, Wu X, Mathews M, Nasrallah HA

Neuropsychiatric Disease and Treatment 2017, 13:2021-2035

Published Date: 31 July 2017

Abnormal intrinsic functional hubs in alcohol dependence: evidence from a voxelwise degree centrality analysis

Luo X, Guo LH, Dai XJ, Wang Q, Zhu W, Miao X, Gong H

Neuropsychiatric Disease and Treatment 2017, 13:2011-2020

Published Date: 28 July 2017

Electrophysiological findings of Turkish patients with restless legs syndrome

Özsimsek A, Koyuncuoglu HR

Neuropsychiatric Disease and Treatment 2017, 13:2005-2010

Published Date: 27 July 2017

Involvement of up-regulation of miR-210 in a rat epilepsy model [Corrigendum]

Chen L, Zheng H, Zhang S

Neuropsychiatric Disease and Treatment 2017, 13:2003-2004

Published Date: 26 July 2017

Sleep problems in university students – an intervention

Schlarb AA, Friedrich A, Claßen M

Neuropsychiatric Disease and Treatment 2017, 13:1989-2001

Published Date: 26 July 2017

The economic burden of schizophrenia in Malaysia

Teoh SL, Chong HY, Abdul Aziz S, Chemi N, Othman AR, Md Zaki N, Vanichkulpitak P, Chaiyakunapruk N

Neuropsychiatric Disease and Treatment 2017, 13:1979-1987

Published Date: 28 July 2017

Risperidone-induced reversible neutropenia

Kattalai Kailasam V, Chima V, Nnamdi U, Sharma K, Shah K

Neuropsychiatric Disease and Treatment 2017, 13:1975-1977

Published Date: 25 July 2017

Spontaneous alterations of regional brain activity in patients with adult generalized anxiety disorder

Xia L, Li S, Wang T, Guo Y, Meng L, Feng Y, Cui Y, Wang F, Ma J, Jiang G

Neuropsychiatric Disease and Treatment 2017, 13:1957-1965

Published Date: 20 July 2017

SoCIAL – training cognition in schizophrenia: a pilot study

Palumbo D, Mucci A, Piegari G, D'Alise V, Mazza A, Galderisi S

Neuropsychiatric Disease and Treatment 2017, 13:1947-1956

Published Date: 20 July 2017

The regional neuronal activity in left posterior middle temporal gyrus is correlated with the severity of chronic aphasia

Li J, Du D, Gao W, Sun X, Xie H, Zhang G, Li J, Li H, Li K

Neuropsychiatric Disease and Treatment 2017, 13:1937-1945

Published Date: 20 July 2017

Impact of help-seeking behavior and partner support on postpartum depression among Saudi women

Almutairi AF, Salam M, Alanazi S, Alweldawi M, Alsomali N, Alotaibi N

Neuropsychiatric Disease and Treatment 2017, 13:1929-1936

Published Date: 20 July 2017

Convulsive syncope related to a small dose of quetiapine in an adolescent with bipolar disorder

Lai J, Lu Q, Huang T, Hu S, Xu Y

Neuropsychiatric Disease and Treatment 2017, 13:1905-1908

Published Date: 19 July 2017

Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study

Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny AN, Nemr AA, Hassan A, Hegazy MI, Mourad HS, Kishk NA, Nada MA, Abdelalim A, Fouad AM, Shehata HS

Neuropsychiatric Disease and Treatment 2017, 13:1895-1903

Published Date: 18 July 2017

Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC-DIM)

Goorden M, van der Feltz-Cornelis CM, van Steenbergen-Weijenburg KM, Horn EK, Beekman ATF, Hakkaart-van Roijen L

Neuropsychiatric Disease and Treatment 2017, 13:1881-1893

Published Date: 18 July 2017

Prevalence, symptomatic features, and factors associated with sleep disturbance/insomnia in Japanese patients with type-2 diabetes

Narisawa H, Komada Y, Miwa T, Shikuma J, Sakurai M, Odawara M, Inoue Y

Neuropsychiatric Disease and Treatment 2017, 13:1873-1880

Published Date: 18 July 2017

Excoriation (skin-picking) disorder: a systematic review of treatment options

Lochner C, Roos A, Stein DJ

Neuropsychiatric Disease and Treatment 2017, 13:1867-1872

Published Date: 14 July 2017

Depression in blepharospasm: a question of facial feedback?

Bedarf JR, Kebir S, Michelis JP, Wabbels B, Paus S

Neuropsychiatric Disease and Treatment 2017, 13:1861-1865

Published Date: 14 July 2017

Genetic and epigenetic mechanisms of epilepsy: a review

Chen T, Giri M, Xia ZY, Subedi YN, Li Y

Neuropsychiatric Disease and Treatment 2017, 13:1841-1859

Published Date: 13 July 2017

Anxiety sensitivity as a predictor of broad dimensions of psychopathology after cognitive behavioral therapy for panic disorder

Ino K, Ogawa S, Kondo M, Imai R, Ii T, Furukawa TA, Akechi T

Neuropsychiatric Disease and Treatment 2017, 13:1835-1840

Published Date: 13 July 2017

Real-time functional magnetic resonance imaging in obsessive-compulsive disorder

Gonçalves ÓF, Batistuzzo MC, Sato JR

Neuropsychiatric Disease and Treatment 2017, 13:1825-1834

Published Date: 12 July 2017

The most important psychological and psychosocial needs of Polish multiple sclerosis patients and their significant others

Potemkowski A, Brola W, Ratajczak A, Ratajczak M, Kowalewski M, Lewita M, Kapica-Topczewska K, Tarasiuk J, Stępień A, Gocyla-Dudar K, Zaborski J, Bartosik-Psujek H

Neuropsychiatric Disease and Treatment 2017, 13:1817-1824

Published Date: 12 July 2017

Long-acting formulations delivering aripiprazole: beyond single-value characterizations of steady-state pharmacokinetics

McConnell SA, Desai DN, Faldu SP, Hard ML, Wehr AY, Weiden PJ, von Moltke L

Neuropsychiatric Disease and Treatment 2017, 13:1815-1816

Published Date: 12 July 2017

Sleep disturbances among patients with epilepsy

Staniszewska A, Mąka A, Religioni U, Olejniczak D

Neuropsychiatric Disease and Treatment 2017, 13:1797-1803

Published Date: 10 July 2017

Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis

Chen F, Su X, Lin Z, Lin Y, Yu L, Cai J, Kang D, Hu L

Neuropsychiatric Disease and Treatment 2017, 13:1771-1782

Published Date: 7 July 2017

Attention–memory training yields behavioral and academic improvements in children diagnosed with attention-deficit hyperactivity disorder comorbid with a learning disorder

Farias AC, Cordeiro ML, Felden EPG, Bara TS, Benko CR, Coutinho D, Martins LF, Ferreira RTC, McCracken JT

Neuropsychiatric Disease and Treatment 2017, 13:1761-1769

Published Date: 6 July 2017

Brain regions associated with anosognosia for memory disturbance in Alzheimer’s disease: a magnetic resonance imaging study

Fujimoto H, Matsuoka T, Kato Y, Shibata K, Nakamura K, Yamada K, Narumoto J

Neuropsychiatric Disease and Treatment 2017, 13:1753-1759

Published Date: 5 July 2017

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity

Huss M, Duhan P, Gandhi P, Chen CW, Spannhuth CW, Kumar V

Neuropsychiatric Disease and Treatment 2017, 13:1741-1751

Published Date: 4 July 2017

Neuroprotective effects of curdione against focal cerebral ischemia reperfusion injury in rats

Li XJ, Liang L, Shi HX, Sun XP, Wang J, Zhang LS

Neuropsychiatric Disease and Treatment 2017, 13:1733-1740

Published Date: 30 June 2017

Reduced prefrontal activation during verbal fluency task in chronic insomnia disorder: a multichannel near-infrared spectroscopy study

Sun JJ, Liu XM, Shen CY, Zhang XQ, Sun GX, Feng K, Xu B, Ren XJ, Ma XY, Liu PZ

Neuropsychiatric Disease and Treatment 2017, 13:1723-1731

Published Date: 30 June 2017

The use of natalizumab for multiple sclerosis

Brandstadter R, Katz Sand I

Neuropsychiatric Disease and Treatment 2017, 13:1691-1702

Published Date: 28 June 2017

Adapting the short form of the Coping Inventory for Stressful Situations into Chinese

Li C, Liu Q, Hu T, Jin X

Neuropsychiatric Disease and Treatment 2017, 13:1669-1675

Published Date: 27 June 2017

The role of microglia in multiple sclerosis

Luo C, Jian C, Liao Y, Huang Q, Wu Y, Liu X, Zou D, Wu Y

Neuropsychiatric Disease and Treatment 2017, 13:1661-1667

Published Date: 26 June 2017

Brain metabolite values in children with breath-holding spells

Calik M, Sen Dokumaci D, Sarikaya S, Demir M, Isik I, Kazanasmaz H, Kaya C, Kandemir H

Neuropsychiatric Disease and Treatment 2017, 13:1655-1660

Published Date: 26 June 2017

Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder

Bu XS, Wu D, Lu XM, Yang L, Xu XY, Wang J, Tang JL

Neuropsychiatric Disease and Treatment 2017, 13:1633-1645

Published Date: 23 June 2017

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review

Correia-Melo FS, Argolo FC, Araújo-de-Freitas L, Leal GC, Kapczinski F, Lacerda AL, Quarantini LC

Neuropsychiatric Disease and Treatment 2017, 13:1627-1632

Published Date: 21 June 2017

Effects of subthalamic nucleus deep brain stimulation on emotional working memory capacity and mood in patients with Parkinson's disease

Merkl A, Röck E, Schmitz-Hübsch T, Schneider G, Kühn AA

Neuropsychiatric Disease and Treatment 2017, 13:1603-1611

Published Date: 19 June 2017

Stress reactivity and emotion in premenstrual syndrome

Liu Q, Wang Y, van Heck CH, Qiao W

Neuropsychiatric Disease and Treatment 2017, 13:1597-1602

Published Date: 16 June 2017

Clinical features of limbic encephalitis with LGI1 antibody

Wang ML, Cao XY, Liu QX, Ma W, Guo XQ, Liu XW

Neuropsychiatric Disease and Treatment 2017, 13:1589-1596

Published Date: 16 June 2017

Suicide and Lyme and associated diseases

Bransfield RC

Neuropsychiatric Disease and Treatment 2017, 13:1575-1587

Published Date: 16 June 2017

Risk factors for the existence of attention deficit hyperactivity disorder symptoms in children with autism spectrum disorders

Lamanna AL, Craig F, Matera E, Simone M, Buttiglione M, Margari L

Neuropsychiatric Disease and Treatment 2017, 13:1559-1567

Published Date: 15 June 2017

De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke

Gao F, Chen C, Lu J, Zheng J, Ma XC, Yuan XY, Huo K, Han JF

Neuropsychiatric Disease and Treatment 2017, 13:1551-1557

Published Date: 15 June 2017

Intelligence profiles of Chinese school-aged boys with high-functioning ASD and ADHD

Li G, Jiang W, Du Y, Rossbach K

Neuropsychiatric Disease and Treatment 2017, 13:1541-1549

Published Date: 15 June 2017

Burnout and compassion fatigue: prevalence and associations among Israeli burn clinicians

Haik J, Brown S, Liran A, Visentin D, Sokolov A, Zilinsky I, Kornhaber R

Neuropsychiatric Disease and Treatment 2017, 13:1533-1540

Published Date: 15 June 2017

Pituitary abscess: report of two cases and review of the literature

Liu Y, Liu F, Liang Q, Li Y, Wang ZF

Neuropsychiatric Disease and Treatment 2017, 13:1521-1526

Published Date: 13 June 2017

Effects of Canon chord progression on brain activity and motivation are dependent on subjective feelings, not the chord progression per se

Kayashima Y, Yamamuro K, Makinodan M, Nakanishi Y, Wanaka A, Kishimoto T

Neuropsychiatric Disease and Treatment 2017, 13:1499-1508

Published Date: 12 June 2017

Sleep apnea leading to Parkinson’s disease – an important association

Shafqat MN, Aadil M, Shoaib M

Neuropsychiatric Disease and Treatment 2017, 13:1491-1492

Published Date: 9 June 2017

PAC1 receptor (ADCYAP1R1) genotype and problematic alcohol use in a sample of young women

Dragan WŁ, Czerski PM, Dragan M

Neuropsychiatric Disease and Treatment 2017, 13:1483-1489

Published Date: 8 June 2017

Disrupted small-world brain functional network topology in male patients with severe obstructive sleep apnea revealed by resting-state fMRI

Chen L, Fan X, Li H, Nie S, Gong H, Zhang W, Zeng X, Long P, Peng D

Neuropsychiatric Disease and Treatment 2017, 13:1471-1482

Published Date: 8 June 2017

Regional impairment of intrinsic functional connectivity strength in patients with chronic primary insomnia

Huang S, Zhou F, Jiang J, Huang M, Zeng X, Ding S, Gong H

Neuropsychiatric Disease and Treatment 2017, 13:1449-1462

Published Date: 6 June 2017

Ictal blinking, an under-recognized phenomenon: our experience and literature review

Saporito MAN, Vitaliti G, Pavone P, Di Stefano G, Striano P, Caraballo RH, Falsaperla R

Neuropsychiatric Disease and Treatment 2017, 13:1435-1439

Published Date: 31 May 2017

Effects of stimulus parameters on motor seizure duration in electroconvulsive therapy

Joo SW, Joo YH, Kim CY, Lee JS

Neuropsychiatric Disease and Treatment 2017, 13:1427-1434

Published Date: 29 May 2017

The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study

Rosic T, Naji L, Bawor M, Dennis BB, Plater C, Marsh DC, Thabane L, Samaan Z

Neuropsychiatric Disease and Treatment 2017, 13:1399-1408

Published Date: 24 May 2017

Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia

Aksay SS, Bumb JM, Remennik D, Thiel M, Kranaster L, Sartorius A, Janke C

Neuropsychiatric Disease and Treatment 2017, 13:1389-1394

Published Date: 23 May 2017

Developmental and behavioral outcomes of uncomplicated monochorionic diamniotic twins born in the third trimester

Sierakowski A, Eapen V, Črnčec R, Smoleniec J

Neuropsychiatric Disease and Treatment 2017, 13:1373-1384

Published Date: 19 May 2017

Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report

Matsui K, Takaesu Y, Inoue T, Inada K, Nishimura K

Neuropsychiatric Disease and Treatment 2017, 13:1367-1371

Published Date: 19 May 2017

Productivity and deadweight losses due to relapses of schizophrenia in Japan

Nakamura Y, Mahlich J

Neuropsychiatric Disease and Treatment 2017, 13:1341-1348

Published Date: 17 May 2017

Potential role of pre- and postnatal testosterone levels in attention-deficit/hyperactivity disorder: is there a sex difference?

Wang LJ, Chou MC, Chou WJ, Lee MJ, Lee SY, Lin PY, Lee YH, Yang YH, Yen CF

Neuropsychiatric Disease and Treatment 2017, 13:1331-1339

Published Date: 16 May 2017

Psychosis in parkinsonism: an unorthodox approach

Onofrj M, Carrozzino D, D'Amico A, Di Giacomo R, Delli Pizzi S, Thomas A, Onofrj V, Taylor JP, Bonanni L

Neuropsychiatric Disease and Treatment 2017, 13:1313-1330

Published Date: 16 May 2017

Robot-assisted gait training for stroke patients: current state of the art and perspectives of robotics

Morone G, Paolucci S, Cherubini A, De Angelis D, Venturiero V, Coiro P, Iosa M

Neuropsychiatric Disease and Treatment 2017, 13:1303-1311

Published Date: 15 May 2017

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population

Kishi T, Ikuta T, Matsunaga S, Matsuda Y, Oya K, Iwata N

Neuropsychiatric Disease and Treatment 2017, 13:1281-1302

Published Date: 11 May 2017

ESSENCE-Q – used as a screening tool for neurodevelopmental problems in public health checkups for young children in south Japan

Hatakenaka Y, Ninomiya H, Billstedt E, Fernell E, Gillberg C

Neuropsychiatric Disease and Treatment 2017, 13:1271-1280

Published Date: 10 May 2017

Novel urinary metabolite signature for diagnosing postpartum depression

Lin L, Chen X, Liu R

Neuropsychiatric Disease and Treatment 2017, 13:1263-1270

Published Date: 10 May 2017

Biomarkers for depression: recent insights, current challenges and future prospects

Strawbridge R, Young AH, Cleare AJ

Neuropsychiatric Disease and Treatment 2017, 13:1245-1262

Published Date: 10 May 2017

Factor structure, reliability, and validity of the Japanese version of the Hoarding Rating Scale-Self-Report (HRS-SR-J)

Tsuchiyagaito A, Horiuchi S, Igarashi T, Kawanori Y, Hirano Y, Yabe H, Nakagawa A

Neuropsychiatric Disease and Treatment 2017, 13:1235-1243

Published Date: 9 May 2017

Stigma associated with mental illness: perspectives of university students in Qatar

Zolezzi M, Bensmail N, Zahrah F, Khaled SM, El-Gaili T

Neuropsychiatric Disease and Treatment 2017, 13:1221-1233

Published Date: 9 May 2017

New standardized nursing cooperation workflow to reduce stroke thrombolysis delays in patients with acute ischemic stroke

Zhou Y, Xu Z, Liao J, Feng F, Men L, Xu L, He Y, Li G

Neuropsychiatric Disease and Treatment 2017, 13:1215-1220

Published Date: 9 May 2017

Anorexia nervosa of the restrictive type and celiac disease in adolescence

Nacinovich R, Tremolizzo L, Corbetta F, Conti E, Neri F, Bomba M

Neuropsychiatric Disease and Treatment 2017, 13:1211-1214

Published Date: 4 May 2017

Connectivity to computers and the Internet among patients with schizophrenia spectrum disorders: a cross-sectional study

Välimäki M, Kuosmanen L, Hätönen H, Koivunen M, Pitkänen A, Athanasopoulou C, Anttila M

Neuropsychiatric Disease and Treatment 2017, 13:1201-1209

Published Date: 27 April 2017

Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients

Talih FR, Ajaltouni JJ, Tamim HM, Kobeissy FH

Neuropsychiatric Disease and Treatment 2017, 13:1193-1200

Published Date: 26 April 2017

Protective efficacy of a single salvianolic acid A treatment on photothrombosis-induced sustained spatial memory impairments

Jiao CX, Zhou H, Yang CX, Ma C, Yang YX, Mao RR, Xu L, Zhou QX

Neuropsychiatric Disease and Treatment 2017, 13:1181-1192

Published Date: 26 April 2017

The genetic relationship between epilepsy and hemiplegic migraine

Huang Y, Xiao H, Qin X, Nong Y, Zou D, Wu Y

Neuropsychiatric Disease and Treatment 2017, 13:1175-1179

Published Date: 24 April 2017

Trichotillomania: the impact of treatment history on the outcome of an Internet-based intervention

Weidt S, Bruhl AB, Delsignore A, Zai G, Kuenburg A, Klaghofer R, Rufer M

Neuropsychiatric Disease and Treatment 2017, 13:1153-1162

Published Date: 21 April 2017

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole

Salzman PM, Raoufinia A, Legacy S, Such P, Eramo A

Neuropsychiatric Disease and Treatment 2017, 13:1125-1129

Published Date: 20 April 2017

Long-term effect of galantamine on cognitive function in patients with Alzheimer’s disease versus a simulated disease trajectory: an observational study in the clinical setting

Nakagawa R, Ohnishi T, Kobayashi H, Yamaoka T, Yajima T, Tanimura A, Kato T, Yoshizawa K

Neuropsychiatric Disease and Treatment 2017, 13:1115-1124

Published Date: 19 April 2017

Perceived parental affectionless control is associated with high neuroticism

Takahashi N, Suzuki A, Matsumoto Y, Shirata T, Otani K

Neuropsychiatric Disease and Treatment 2017, 13:1111-1114

Published Date: 18 April 2017

Levodopa-responsive depression associated with corticobasal degeneration: a case report

Tarakita N, Nishijima H, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2017, 13:1107-1110

Published Date: 18 April 2017

Psychosis in behavioral variant frontotemporal dementia

Gossink FT, Vijverberg EGB, Krudop W, Scheltens P, Stek ML, Pijnenburg YAL, Dols A

Neuropsychiatric Disease and Treatment 2017, 13:1099-1106

Published Date: 13 April 2017

Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication

Yang FD, Li J, Tan YL, Liang WY, Zhang R, Wang N, Feng W, Cai S, Zhuo JM, Zhang LL

Neuropsychiatric Disease and Treatment 2017, 13:1089-1097

Published Date: 13 April 2017

Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with schizophrenia

Kadasah S, Arfin M, Rizvi S, Al-Asmari M, Al-Asmari A

Neuropsychiatric Disease and Treatment 2017, 13:1081-1088

Published Date: 12 April 2017

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?

Chan MH, Leung PW, Ho TP, Hung SF, Lee CC, Tang CP, Cheung KC, Ching FY, Chan FH, Chen LH, Garcia-Barcelo M, Sham PC

Neuropsychiatric Disease and Treatment 2017, 13:1071-1080

Published Date: 11 April 2017

Metabolic screening and its impact in children with non-syndromic intellectual disability

Ali YF, EL-Morshedy S, Elsayed RM, EL-sherbini AM, El-Sayed SAM, Abdrahman NIA, Imam AA

Neuropsychiatric Disease and Treatment 2017, 13:1065-1070

Published Date: 19 April 2017

Clinical and biochemical study of D-serine metabolism among schizophrenia patients

El-Tallawy HN, Saleem TH, El-Ebidi AMA, Hassan MH, Gabra RH, Farghaly WMA, Abo El-Maali N, Sherkawy HS

Neuropsychiatric Disease and Treatment 2017, 13:1057-1063

Published Date: 10 April 2017

Pathogenic beliefs among patients with depressive disorders

Neelapaijit A, Wongpakaran T, Wongpakaran N, Thongpibul K

Neuropsychiatric Disease and Treatment 2017, 13:1047-1055

Published Date: 10 April 2017

Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report

Horikoshi S, Miura I, Kunii Y, Asano S, Kanno-Nozaki K, Mashiko H, Yabe H

Neuropsychiatric Disease and Treatment 2017, 13:1043-1045

Published Date: 7 April 2017

Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis

Maneeton B, Putthisri S, Maneeton N, Woottiluk P, Suttajit S, Charnsil C, Srisurapanont M

Neuropsychiatric Disease and Treatment 2017, 13:1023-1032

Published Date: 4 April 2017

Relationship between hypnosis and personality trait in participants with high or low hypnotic susceptibility

Zhang Y, Wang Y, Shen C, Ye Y, Shen S, Zhang B, Wang J, Chen W, Wang W

Neuropsychiatric Disease and Treatment 2017, 13:1007-1012

Published Date: 3 April 2017

An Internet-based program for depressive symptoms using human and automated support: a randomized controlled trial

Mira A, Bretón-López J, García-Palacios A, Quero S, Baños RM, Botella C

Neuropsychiatric Disease and Treatment 2017, 13:987-1006

Published Date: 31 March 2017

Punding following posterior cerebral artery infarction: a case report and review of literature

Lin CI, Lin YC, Lien WC, Hsieh PC, Lin SH, Kuan TS

Neuropsychiatric Disease and Treatment 2017, 13:981-985

Published Date: 31 March 2017

Twelve-week physical exercise does not have a long-lasting effect on kynurenines in plasma of depressed patients

Millischer V, Erhardt S, Ekblom Ö, Forsell Y, Lavebratt C

Neuropsychiatric Disease and Treatment 2017, 13:967-972

Published Date: 31 March 2017

Sleep apnea and the subsequent risk of Parkinson’s disease: a 3-year nationwide population-based study

Chou PS, Lai CL, Chou YH, Chang WP

Neuropsychiatric Disease and Treatment 2017, 13:959-965

Published Date: 30 March 2017

Comparing the ability of cognitive and affective Theory of Mind in adolescent onset schizophrenia

Li D, Li X, Yu F, Chen X, Zhang L, Li D, Wei Q, Zhang Q, Zhu C, Wang K

Neuropsychiatric Disease and Treatment 2017, 13:937-945

Published Date: 27 March 2017

Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia–reperfusion injury in rats by targeting multiple cellular processes

Wang M, Zhang Y, Feng L, Zheng J, Fan S, Liu J, Yang N, Liu Y, Zuo P

Neuropsychiatric Disease and Treatment 2017, 13:927-935

Published Date: 27 March 2017

The Maugeri Stress Index – reduced form: a questionnaire for job stress assessment

Massidda D, Giorgi I, Vidotto G, Tringali S, Imbriani M, Baiardi P, Bertolotti G

Neuropsychiatric Disease and Treatment 2017, 13:917-926

Published Date: 24 March 2017

Illness denial questionnaire for patients and caregivers

Rossi Ferrario S, Giorgi I, Baiardi P, Giuntoli L, Balestroni G, Cerutti P, Manera M, Gabanelli P, Solara V, Fornara R, Luisetti M, Omarini P, Omarini G, Vidotto G

Neuropsychiatric Disease and Treatment 2017, 13:909-916

Published Date: 23 March 2017

Association study of MIF promoter polymorphisms with suicide completers in the Japanese population

Shimmyo N, Hishimoto A, Otsuka I, Okazaki S, Boku S, Mouri K, Horai T, Takahashi M, Ueno Y, Shirakawa O, Sora I

Neuropsychiatric Disease and Treatment 2017, 13:899-908

Published Date: 22 March 2017

Dynamic balance in children with attention-deficit hyperactivity disorder and its relationship with cognitive functions and cerebellum

Goetz M, Schwabova JP, Hlavka Z, Ptacek R, Surman CBH

Neuropsychiatric Disease and Treatment 2017, 13:873-880

Published Date: 21 March 2017

Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion

Katahira H, Sunagawa M, Watanabe D, Kanada Y, Katayama A, Yamauchi R, Takashima M, Ishikawa S, Hisamitsu T

Neuropsychiatric Disease and Treatment 2017, 13:863-872

Published Date: 20 March 2017

Long-term efficacy and safety of lamotrigine for all types of bipolar disorder

Watanabe Y, Hongo S

Neuropsychiatric Disease and Treatment 2017, 13:843-854

Published Date: 20 March 2017

Some children with autism have latent social skills that can be tested

Hrdlicka M, Urbanek T, Vacova M, Beranova S, Dudova I

Neuropsychiatric Disease and Treatment 2017, 13:827-833

Published Date: 16 March 2017

Neuropsychiatric symptoms in untreated Parkinson’s disease

Szatmari S, Illigens BM, Siepmann T, Pinter A, Takats A, Bereczki D

Neuropsychiatric Disease and Treatment 2017, 13:815-826

Published Date: 16 March 2017

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder

Jha MK, Teer RB, Minhajuddin A, Greer TL, Rush AJ, Trivedi MH

Neuropsychiatric Disease and Treatment 2017, 13:803-813

Published Date: 15 March 2017

Validation and cultural adaptation of the Arabic versions of the Mini–Mental Status Examination – 2 and Mini-Cog test

Albanna M, Yehya A, Khairi A, Dafeeah E, Elhadi A, Rezgui L, Al Kahlout S, Yousif A, Uthman B, Al-Amin H

Neuropsychiatric Disease and Treatment 2017, 13:793-801

Published Date: 14 March 2017

Attention-deficit hyperactivity disorder in elementary school students in Shantou, China: prevalence, subtypes, and influencing factors

Huang Y, Zheng S, Xu C, Lin K, Wu K, Zheng M, Zhang J, Xu H

Neuropsychiatric Disease and Treatment 2017, 13:785-792

Published Date: 14 March 2017

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan

Sugawara N, Danjo K, Furukori H, Sato Y, Tomita T, Fujii A, Nakagami T, Kitaoka K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2017, 13:779-784

Published Date: 13 March 2017

Preliminary evaluation of a “formulation-driven cognitive behavioral guided self-help (fCBT-GSH)” for crisis and transitional case management clients

Naeem F, Johal RK, Mckenna C, Calancie O, Munshi T, Hassan T, Nasar A, Ayub M

Neuropsychiatric Disease and Treatment 2017, 13:769-774

Published Date: 10 March 2017

Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults [Corrigendum]

Nakato Y, Inoue T, Nakagawa S, Kitaichi Y, Kameyama R, Wakatsuki Y, Kitagawa K, Omiya Y, Kusumi I

Neuropsychiatric Disease and Treatment 2017, 13:767-768

Published Date: 9 March 2017

Lithium in late-life mania: a systematic review

De Fazio P, Gaetano R, Caroleo M, Pavia M, De Sarro G, Fagiolini A, Segura-Garcia C

Neuropsychiatric Disease and Treatment 2017, 13:755-766

Published Date: 9 March 2017

Monitoring brain multiparameters and hypothermia in severe traumatic brain injury

Vasconcelos FR, Andrade AF, Teixeira MJ, Paiva WS

Neuropsychiatric Disease and Treatment 2017, 13:721-722

Published Date: 8 March 2017

Prevalence of dementia in Egypt: a systematic review

Elshahidi MH, Elhadidi MA, Sharaqi AA, Mostafa A, Elzhery MA

Neuropsychiatric Disease and Treatment 2017, 13:715-720

Published Date: 6 March 2017

New opinion on the subtypes of poststroke depression in Chinese stroke survivors

Yue Y, Liu R, Cao Y, Wu Y, Zhang S, Li H, Zhu J, Jiang W, Wu A, Yuan Y

Neuropsychiatric Disease and Treatment 2017, 13:707-713

Published Date: 6 March 2017

Influence of CFH gene on symptom severity of schizophrenia

Zhang C, Lv QY, Fan WX, Tang W, Yi ZH

Neuropsychiatric Disease and Treatment 2017, 13:697-706

Published Date: 2 March 2017

Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan

Cheng YS, Shyu YC, Lee SY, Yuan SS, Yang CJ, Yang KC, Lee TL, Wang LJ

Neuropsychiatric Disease and Treatment 2017, 13:643-651

Published Date: 1 March 2017

Screening for bipolar disorder among migraineurs: the impact of migraine–bipolar disorder comorbidity on disease characteristics

Kivilcim Y, Altintas M, Domac FM, Erzincan E, Gülec H

Neuropsychiatric Disease and Treatment 2017, 13:631-641

Published Date: 1 March 2017

Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study

Horsdal HT, Benros ME, Köhler-Forsberg O, Krogh J, Gasse C

Neuropsychiatric Disease and Treatment 2017, 13:621-630

Published Date: 28 February 2017

Quality of life in children and adolescents with obsessive–compulsive disorder: a systematic review and meta-analysis

Coluccia A, Ferretti F, Fagiolini A, Pozza A

Neuropsychiatric Disease and Treatment 2017, 13:597-608

Published Date: 24 February 2017

Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms

Rao G, Mashkouri S, Aum D, Marcet P, Borlongan CV

Neuropsychiatric Disease and Treatment 2017, 13:585-596

Published Date: 23 February 2017

Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive–compulsive disorder

Takeda T, Sumitani S, Hamatani S, Yokose Y, Shikata M, Ohmori T

Neuropsychiatric Disease and Treatment 2017, 13:577-583

Published Date: 23 February 2017

Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Kamaradova D, Marackova M, Holubova M, Grambal A, Slepecky M, Latalova K

Neuropsychiatric Disease and Treatment 2017, 13:567-576

Published Date: 23 February 2017

Gender differences in the association between HTR2C gene variants and suicidal behavior in a Mexican population: a case–control study

Molina-Guzman G, González-Castro TB, Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop IE, Guzmán-Priego CG, Genis A, Pool García S, López-Narvaez ML, Rodriguez-Perez JM

Neuropsychiatric Disease and Treatment 2017, 13:559-566

Published Date: 22 February 2017

Assessment of poststroke mania and diagnosis

Shoaib M, Aadil M

Neuropsychiatric Disease and Treatment 2017, 13:557-558

Published Date: 21 February 2017

Validation of the Revised Illness Perception Questionnaire in Turkish epilepsy patients and the effects of earthquake experience on perception of disease

Keskin Güler S, Güler S, Gökçe Çokal B, Gunes N, Yon Mİ, Yoldas TK

Neuropsychiatric Disease and Treatment 2017, 13:551-556

Published Date: 21 February 2017

Analysis concerning nutritional behaviors in the context of the risk of orthorexia

Olejniczak D, Bugajec D, Panczyk M, Brytek-Matera A, Religioni U, Czerw A, Grąbczewska A, Juszczyk G, Jabłkowska-Górecka K, Staniszewska A

Neuropsychiatric Disease and Treatment 2017, 13:543-550

Published Date: 21 February 2017

Gene expression-based biological test for major depressive disorder: an advanced study

Watanabe S, Numata S, Iga J, Kinoshita M, Umehara H, Ishii K, Ohmori T

Neuropsychiatric Disease and Treatment 2017, 13:535-541

Published Date: 21 February 2017

Association of carotid atherosclerosis and recurrent cerebral infarction in the Chinese population: a meta-analysis

Liu J, Zhu Y, Wu Y, Liu Y, Teng Z, Hao Y

Neuropsychiatric Disease and Treatment 2017, 13:527-533

Published Date: 20 February 2017

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population

Jiang KD, Li LJ, Wang XY, Fang MS, Shi JF, Cao QY, He JC, Wang JN, Tan WH, Hu CL

Neuropsychiatric Disease and Treatment 2017, 13:515-526

Published Date: 17 February 2017

Abnormal resting-state brain activities in patients with first-episode obsessive-compulsive disorder

Niu Q, Yang L, Song X, Chu C, Liu H, Zhang L, Li Y, Zhang X, Cheng J, Li Y

Neuropsychiatric Disease and Treatment 2017, 13:507-513

Published Date: 16 February 2017

Blood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approach

Landgren M, Nasic S, Johnson M, Lövoll T, Holmgren D, Fernell E

Neuropsychiatric Disease and Treatment 2017, 13:499-506

Published Date: 16 February 2017

Efficacy and safety of Ginkgo biloba standardized extract in the treatment of vascular cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial

Demarin V, Bašić Kes V, Trkanjec Z, Budišić M, Bošnjak Pašić M, Črnac P, Budinčević H

Neuropsychiatric Disease and Treatment 2017, 13:483-490

Published Date: 16 February 2017

Associations among depressive symptoms, childhood abuse, neuroticism, and adult stressful life events in the general adult population

Ono K, Takaesu Y, Nakai Y, Shimura A, Ono Y, Murakoshi A, Matsumoto Y, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2017, 13:477-482

Published Date: 15 February 2017

Delirium after a traumatic brain injury: predictors and symptom patterns

Maneewong J, Maneeton B, Maneeton N, Vaniyapong T, Traisathit P, Sricharoen N, Srisurapanont M

Neuropsychiatric Disease and Treatment 2017, 13:459-465

Published Date: 14 February 2017

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control

Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS

Neuropsychiatric Disease and Treatment 2017, 13:443-455

Published Date: 13 February 2017

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder

Yoshimura R, Katsuki A, Atake K, Hori H, Igata R, Konishi Y

Neuropsychiatric Disease and Treatment 2017, 13:437-441

Published Date: 14 February 2017

Abnormal whole-brain functional connectivity in patients with primary insomnia

Li C, Dong M, Yin Y, Hua K, Fu S, Jiang G

Neuropsychiatric Disease and Treatment 2017, 13:427-435

Published Date: 13 February 2017

The dynamic relationship between emotional and physical states: an observational study of personal health records

Lee YS, Jung WM, Jang H, Kim S, Chung SY, Chae Y

Neuropsychiatric Disease and Treatment 2017, 13:411-419

Published Date: 9 February 2017

Resting-state functional connectivity changes within the default mode network and the salience network after antipsychotic treatment in early-phase schizophrenia

Wang Y, Tang W, Fan X, Zhang J, Geng D, Jiang K, Zhu D, Song Z, Xiao Z, Liu D

Neuropsychiatric Disease and Treatment 2017, 13:397-406

Published Date: 7 February 2017

Risk assessment of aggressive behavior in Chinese patients with schizophrenia by fMRI and COMT gene

Tang X, Jin J, Tang Y, Cao J, Huang J

Neuropsychiatric Disease and Treatment 2017, 13:387-395

Published Date: 7 February 2017

Use of transcranial direct current stimulation for the treatment of auditory hallucinations of schizophrenia – a systematic review

Pondé PH, de Sena EP, Camprodon JA, Araújo AN, Neto MF, DiBiasi M, Baptista AF, Moura LMVR, Cosmo C

Neuropsychiatric Disease and Treatment 2017, 13:347-355

Published Date: 1 February 2017

N-Methyl-D-aspartate receptor antibody could be a cause of catatonic symptoms in psychiatric patients: case reports and methods for detection

Tsutsui K, Kanbayashi T, Takaki M, Omori Y, Imai Y, Nishino S, Tanaka K, Shimizu T

Neuropsychiatric Disease and Treatment 2017, 13:339-345

Published Date: 8 February 2017

Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females

Farhadi F, Vosoughi K, Shahidi GA, Delbari A, Lökk J, Fereshtehnejad SM

Neuropsychiatric Disease and Treatment 2017, 13:329-338

Published Date: 1 February 2017

The parental bonding in families of adolescents with anorexia: attachment representations between parents and offspring

Balottin L, Mannarini S, Rossi M, Rossi G, Balottin U

Neuropsychiatric Disease and Treatment 2017, 13:319-327

Published Date: 1 February 2017

The spectrum of psychosis in multiple sclerosis: a clinical case series

Gilberthorpe TG, O'Connell KE, Carolan A, Silber E, Brex PA, Sibtain NA, David AS

Neuropsychiatric Disease and Treatment 2017, 13:303-318

Published Date: 1 February 2017

The relationship between childhood trauma and adult psychosis in a UK Early Intervention Service: results of a retrospective case note study

Reeder FD, Hussain N, Rhouma A, Haddad PM, Munshi T, Naeem F, Khachatryan D, Chaudhry IB

Neuropsychiatric Disease and Treatment 2017, 13:269-273

Published Date: 8 February 2017

Role of prediabetes in stroke

Mijajlović MD, Aleksić VM, Šternić NM, Mirković MM, Bornstein NM

Neuropsychiatric Disease and Treatment 2017, 13:259-267

Published Date: 2 February 2017

Visual–spatial training efficacy in children affected by migraine without aura: a multicenter study

Precenzano F, Ruberto M, Parisi L, Salerno M, Maltese A, Gallai B, Marotta R, Lavano SM, Lavano F, Roccella M

Neuropsychiatric Disease and Treatment 2017, 13:253-258

Published Date: 27 January 2017

Efficacy of a short cognitive training program in patients with multiple sclerosis

Pérez-Martín MY, González-Platas M, Eguía-del Rio P, Croissier-Elías C, Jiménez Sosa A

Neuropsychiatric Disease and Treatment 2017, 13:245-252

Published Date: 3 February 2017

A survey of eMedia-delivered interventions for schizophrenia used in randomized controlled trials

Naeem F, Munshi T, Xiang S, Yang M, Shokraneh F, Syed Y, Ayub M, Adams CE, Farooq S

Neuropsychiatric Disease and Treatment 2017, 13:233-243

Published Date: 27 January 2017

Construct validity of the Depression and Somatic Symptoms Scale: evaluation by Mokken scale analysis

Chou YH, Lee CP, Liu CY, Hung CI

Neuropsychiatric Disease and Treatment 2017, 13:205-211

Published Date: 23 January 2017

Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study

Ifteni P, Teodorescu A, Moga MA, Pascu AM, Miclaus RS

Neuropsychiatric Disease and Treatment 2017, 13:201-204

Published Date: 23 January 2017

A possible role of the Infant/Toddler Sensory Profile in screening for autism: a proof-of-concept study in the specific sample of prematurely born children with birth weights <1,500 g

Beranova S, Stoklasa J, Dudova I, Markova D, Kasparova M, Zemankova J, Urbanek T, Talasek T, Luukka P, Hrdlicka M

Neuropsychiatric Disease and Treatment 2017, 13:191-200

Published Date: 23 January 2017

A preliminary study of Patient Dignity Inventory validation among patients hospitalized in an acute psychiatric ward

Di Lorenzo R, Cabri G, Carretti E, Galli G, Giambalvo N, Rioli G, Saraceni S, Spiga G, Del Giovane C, Ferri P

Neuropsychiatric Disease and Treatment 2017, 13:177-190

Published Date: 23 January 2017

Neuroleptic malignant syndrome: an easily overlooked neurologic emergency

Oruch R, Pryme IF, Engelsen BA, Lund A

Neuropsychiatric Disease and Treatment 2017, 13:161-175

Published Date: 16 January 2017

Evaluation of the risk factors of depressive disorders comorbid with obstructive sleep apnea

Cai LQ, Xu LY, Wei LL, Sun Y, Chen W

Neuropsychiatric Disease and Treatment 2017, 13:155-159

Published Date: 16 January 2017

Effects of paliperidone extended release on hostility among Thai patients with schizophrenia

Jariyavilas A, Thavichachart N, Kongsakon R, Chantakarn S, Arunpongpaisal S, Chantarasak V, Jaroensook P, Kittiwattanagul K, Nerapusee O

Neuropsychiatric Disease and Treatment 2017, 13:141-146

Published Date: 12 January 2017

Association of peripheral neuropathy with sleep-related breathing disorders in myotonic dystrophies

Banach M, Antczak J, Rola R

Neuropsychiatric Disease and Treatment 2017, 13:133-140

Published Date: 12 January 2017

Quality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective study

Kongsaengdao S, Maneeton B, Maneeton N

Neuropsychiatric Disease and Treatment 2017, 13:127-132

Published Date: 10 January 2017

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial

Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N

Neuropsychiatric Disease and Treatment 2017, 13:117-125

Published Date: 6 January 2017

Cognitive profiles in bilingual children born to immigrant parents and Italian monolingual native children with specific learning disorders

Riva A, Nacinovich R, Bertuletti N, Montrasi V, Marchetti S, Neri F, Bomba M

Neuropsychiatric Disease and Treatment 2017, 13:109-116

Published Date: 30 December 2016

Risperidone improves interpersonal perception and executive function in patients with schizophrenia

Zhou Z, Zhu Y, Wang J, Zhu H

Neuropsychiatric Disease and Treatment 2017, 13:101-107

Published Date: 28 December 2016

Alterations of white matter fractional anisotropy in unmedicated obsessive–compulsive disorder

Tao J, Wang XL, Zhong ZY, Han HY, Liu S, Wen SL, Guan NH, Li LJ

Neuropsychiatric Disease and Treatment 2017, 13:69-76

Published Date: 28 December 2016

A biopsychological review of gambling disorder

Quintero GC

Neuropsychiatric Disease and Treatment 2017, 13:51-60

Published Date: 23 December 2016

Detailed course of depressive symptoms and risk for developing depression in late adolescents with subthreshold depression: a cohort study

Jinnin R, Okamoto Y, Takagaki K, Nishiyama Y, Yamamura T, Okamoto Y, Miyake Y, Takebayashi Y, Tanaka K, Sugiura Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S

Neuropsychiatric Disease and Treatment 2017, 13:25-33

Published Date: 22 December 2016

Temperament, personality, and treatment outcome in major depression: a 6-month preliminary prospective study

Kudo Y, Nakagawa A, Wake T, Ishikawa N, Kurata C, Nakahara M, Nojima T, Mimura M

Neuropsychiatric Disease and Treatment 2017, 13:17-24

Published Date: 19 December 2016

Pioglitazone could induce remission in major depression: a meta-analysis

Colle R, de Larminat D, Rotenberg S, Hozer F, Hardy P, Verstuyft C, Fève B, Corruble E

Neuropsychiatric Disease and Treatment 2017, 13:9-16

Published Date: 19 December 2016

Minocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial

Husain MI, Chaudhry IB, Hamirani MM, Minhas FA, Kazmi A, Hodsoll J, Haddad PM, Deakin JFW, Husain N, Young AH

Neuropsychiatric Disease and Treatment 2017, 13:1-8

Published Date: 19 December 2016